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L-pipecolic acid is a non-protein amino acid commonly found 
in plants, animals, and microorganisms. It is a well-known 
precursor to numerous microbial secondary metabolites and 
pharmaceuticals, including anticancer agents, immunosup-
pressants, and several antibiotics. Lysine cyclodeaminase 
(LCD) catalyzes β-deamination of L-lysine into L-pipecolic acid 
using β-nicotinamide adenine dinucleotide as a cofactor. Ex-
pression of a human homolog of LCD, μ-crystallin, is elevated 
in prostate cancer patients. To understand the structural fea-
tures and catalytic mechanisms of LCD, we determined the 
crystal structures of Streptomyces pristinaespiralis LCD 
(SpLCD) in (i) a binary complex with NAD+, (ii) a ternary com-
plex with NAD+ and L-pipecolic acid, (iii) a ternary complex 
with NAD+ and L-proline, and (iv) a ternary complex with 
NAD+ and L-2,4-diamino butyric acid. The overall structure of 
SpLCD was similar to that of ornithine cyclodeaminase from 
Pseudomonas putida. In addition, SpLCD recognized L-lysine, 
L-ornithine, and L-2,4-diamino butyric acid despite differences 
in the active site, including differences in hydrogen bonding 
by Asp236, which corresponds with Asp228 from Pseudo-
monas putida ornithine cyclodeaminase. The substrate bind-
ing pocket of SpLCD allowed substrates smaller than lysine to 
bind, thus enabling binding to ornithine and L-2,4-diamino 
butyric acid. Our structural and biochemical data facilitate a 
detailed understanding of substrate and product recognition,  
thus providing evidence for a reaction mechanism for SpLCD. 
The proposed mechanism is unusual in that NAD+ is initially 
converted into NADH and then reverted back into NAD+ at a 
late stage of the reaction. 
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INTRODUCTION 
 
L-Pipecolic acid (L-Pip), also known as L-homoproline and 
piperidine-2-carboxylic acid, is a well-known precursor of 
various secondary metabolites in plants, animals, and micro-
organisms (Durzan, 1983; Zacharius et al., 1954). Lysine 
cyclodeaminase (LCD) catalyzes β-deamination of L-lysine 
into L-Pip using β-nicotinamide adenine dinucleotide as a 
cofactor. In humans, L-Pip is synthesized in the brain and 
accumulates in the physiological fluids of patients with pe-
roxisomal disorders, such as hyperpipecolic academia, Zell-
weger syndrome, and infantile Refsum disease (Mihalik et al., 
1989; Rao and Chang, 1992). In these diseases, peroxi-
somes, which are the sites of L-Pip oxidation, are reduced in 
size and number and many peroxisomal enzymes present 
with low activity (Mihalik et al., 1989; Rao and Chang, 1992).  
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Expression of a human LCD homolog, μ-crystallin, is elevated 
in prostate cancer patients (Malinowska et al., 2009). In 
plants, L-Pip acts as an osmoprotectant, inducer of flowering, 
indicator of abnormal amino acid metabolism, and has a 
critical role in plant immunity (Fujioka and Sakurai, 1992; 
Moulin et al., 2006; Návarová et al., 2012; Pálfi and Dézsi, 
1968). In bacteria, L-Pip is synthesized during L-lysine me-
tabolism and acts as an osmoprotectant, thus enabling bac-
teria to grow in hyperosmotic environments (Gouesbet et al., 
1994; Neshich et al., 2013). 
L-Pip is a useful precursor of several pharmaceuticals, in-
cluding the immunosuppressant FK506, rapamycin, the anti-
cancer agent VX710, and the antibiotics demethoxyrapamy-
cin, sandramycin, and meridamycin (Bis et al., 2015; Boger 
et al., 1996; Gatto et al., 2006; Germann et al., 1997; Ka-
douri-Puchot and Comesse, 2005; Watanabe et al., 2005). 
As the importance and utility of L-Pip derivatives have be-
come increasingly well-known, chemists have been develop-
ing different methods by which to synthesize L-Pip (Couty, 
1999; Eichhorn et al., 1997; Lemire and Charette, 2010; 
Wilkinson et al., 2000). In particular, enzymatic production 
of L-Pip using the L-lysine metabolic pathway has been ex-
tensively investigated (Broquist, 1991; Byun et al., 2015; Fujii 
et al., 2002; Garcia et al., 2016; Gupta and Spenser, 1969; 
Miller and Rodwell, 1971; Tani et al., 2015; Ying et al., 2015; 
2017a), because the precursor L-lysine is abundant in nature 
and enzymatic synthesis of L-Pip yields a product with better 
chiral purity than chemical synthesis. Two metabolic path-
ways have previously been investigated for use in the enzy-
matic synthesis of L-Pip (Broquist, 1991; Gupta and Spenser, 
1969; Miller and Rodwell, 1971). However, both of these 
metabolic routes require two or more enzymes and involve 
several steps to produce L-Pip from L-lysine, which results in 
problematic byproducts and high purification costs (He, 
2006). 
By contrast, it has been shown that LCD can directly con-
vert L-lysine into L-Pip in one step using NAD+ as a cofactor 
(Gatto et al., 2006; Tsotsou and Barbirato, 2007), which is 
more efficient than other methods used for L-Pip biosynthe-
sis. Recently, conditions for L-Pip biosynthesis using LCD 
from Streptomyces pristinaespiralis (SpLCD) were optimized 
to increase catalytic efficiency (Byun et al., 2015; Tsotsou 
and Barbirato, 2007; Ying et al., 2015; 2017a). In addition, 
the crystal structures of SpLCD in complex with L-lysine and 
L-Pip have been determined and their modes of binding 
described (Ying et al., 2017b). Interestingly, SpLCD has a 
range of substrates with carbon lengths ranging from 4-6 
carbons. However, it is currently unknown how SpLCD rec-
ognizes and acts on this diverse range of substrates, includ-
ing how L-lysine and L-ornithine are converted into L-Pip and 
L-Proline (L-Pro), respectively. L-lysine has been demonstrat-
ed to be the best substrate for SpLCD, of all the known sub-
strates such as L-2,4-diamino butyric acid (L-DABA), L-
ornithine, and L-lysine, which have four, five, and six carbon 
chains, respectively (Byun et al., 2015). 
The crystal structure and binding of ornithine cyclodeami-
nase (OCD) in complex with ornithine have been described 
(Goodman et al., 2004). Based on OCD X-ray crystallograph-
ic and mass spectroscopic data, a reaction mechanism has 
been proposed for OCD (Gatto et al., 2006; Goodman et al., 
2004). The proposed mechanism is unusual in that NAD+ is 
initially converted into NADH and then reverted back into 
NAD+ at a late stage, where the pyridine nucleotide acts as a 
cosubstrate during most enzymatic reactions that utilize 
NAD(P)+ and NAD(P)H (Gatto et al., 2006). Similar use of 
NAD(P)+ as a catalytic cofactor has been proposed for other 
enzymes, including UDP-galactose 4-epimerase (Frey, 1996), 
S-adenosylhomocysteine hydrolase (Hu et al., 2001), and 
myo-inositol-1-phosphate synthase (Gatto et al., 2006; Jin 
and Geiger, 2003). Mechanisms similar to those utilized by 
OCD have been proposed for LCD. However, the LCD sub-
strate L-lysine contains one carbon more than ornithine. 
Therefore, it would be of interest to determine how LCD and 
OCD active sites recognize their substrates and how their 
reaction mechanisms differ. 
Because of the unusual reaction mechanism suggested for 
LCD and the importance of the reaction product L-Pip, we 
undertook a crystallographic study of LCD derived from S. 
pristinaespiralis. This provided a structural basis for determin-
ing how SpLCD recognizes several substrates, including L-
lysine, L-ornithine, and L-DABA. Here, we report the crystal 
structures of SpLCD in four ligand-bound states: SpLCD/ 
NAD+, SpLCD/NAD+/L-DABA, SpLCD/NAD+/L-Pro, and SpLCD/ 
NAD+/L-Pip. By comparing the binding pockets of LCD and 
OCD, we found the hydrogen bonding residues, including 
Asp236, allow recognition of lysine as a substrate. Our struc-
tural and biochemical data facilitate a detailed understand-
ing of substrate and product recognition by SpLCD, thus 
informing a proposal for the structure-based reaction mech-
anism for SpLCD. 
 
MATERIALS AND METHODS 
 
Cloning and protein preparation 
L-lysine cyclodeaminase from S. pristinaespiralis (amino acids 
1-355) was cloned into the pET21b (+) expression vector. This 
construct encoded an N-terminal His6 tag and the SpLCD gene 
under the control of the T7 promoter. The SpLCD protein was 
produced in Escherichia coli strain BL21 (DE3) by inducing 
expression with 0.5 mM isopropyl-β-D-1-thiogalactopyranoside 
and incubating at 25℃ for 16 h. To lyse the cells, the cells 
were passed through a microfluidizer in lysis buffer A (20 mM 
Tris-HCl, pH 8.0, and 200 mM NaCl) containing 1 mM phe-
nylmethylsulfonyl fluoride and 5% (w/v) glycerol. The lysed 
cells were centrifuged at 4,611 g (Vision V506CA rotor) for 30 
min at 277 K to pellet cellular debris. The resulting superna-
tant was run through Ni-sepharose affinity resin (GE 
Healthcare). Proteins were eluted with buffer A containing 
100-300 mM imidazole, further purified by size exclusion 
chromatography (HiLoad 16/600 Superdex 200 prep grade, 
GE Healthcare), and then concentrated to 30 mg/ml by ultra-
filtration. The extinction coefficient of SpLCD was calculated 
using ProtParam (http://web.expasy.org/protparam).  
Crystallization, determination of structure, and refinement 
Crystals of SpLCD in complex with NAD+ were grown at 298 
K using the sitting drop method Briefly, 1 μl of a 10 mg/ml 
solution of SpLCD in buffer A was mixed with 1 μl of reser-
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voir solution (100 mM CAPSO buffer at pH 9.6, 0.2 M Li2SO4, 
0.9 M Na-K tartrate, and 2% polyethylene glycol 3350) in 
the presence of 10 mM NAD+. For the SpLCD/NAD+/L-DABA, 
SpLCD/NAD+/L-Pro, and SpLCD/NAD+/L-Pip crystals, SpLCD 
was crystallized in the presence of 10 mM L-DABA, 10 mM 
L-ornithine, or 10 mM L-lysine, respectively. For cryoprotec-
tion, the crystals were transferred to reservoir solution con-
taining 25% glycerol. Data was collected at 100 K in 1° oscil-
lations at the 7A beamline of the Pohang Light Source and 
BL26B1 beamline of the SPring-8. 
Crystals of SpLCD/NAD+, SpLCD/NAD+/L-Pip, SpLCD/ 
NAD+/L-Pro, and SpLCD/NAD+/L-DABA complexes were 
diffracted to a resolution of 1.92 Å, 1.92 Å, 1.79 Å, and 
2.14 Å, respectively. The diffraction data were processed 
and scaled using the HKL2000 software package (Otwinow-
ski and Minor, 1997). The SpLCD/NAD+ crystal belonged to 
space group C2 and had unit cell parameters of a = 270.5 Å, 
b = 64.4 Å, and c = 106.4 Å. SpLCD/NAD+/L-Pip crystal also 
belonged to the C2 space group and had unit cell parame-
ters of a = 271.4 Å, b = 64.5 Å, and c = 106.3 Å. The 
SpLCD/NAD+/L-Pro belonged to space group C2 and had 
unit cell parameters of a = 271.5 Å, b = 64.8 Å, and c = 
106.9 Å. SpLCD/NAD+/L-DABA crystal belonged to the C2 
space group and had unit cell parameters of a = 271.1 Å, b 
= 64.8 Å, and c = 106.9. The structures were solved using 
the molecular replacement method using the Archaeoglo-
bus fulgidus alanine dehydrogenase model, Protein Data 
Bank (PDB) entry 1OMO, as a probe (Gallagher et al., 2004). 
 
 
 
Table 1. Statistics for data collection and refinement 
Data set SpLCD with NAD+ SpLCD with NAD+ 
and L-Pip 
SpLCD with NAD+ 
and L-Pro 
SpLCD with NAD+ 
and DABA 
A. Data collection 
X-ray source PLS7A  PLS7A SPring-8 BL26B1 SPring-8 BL26B1 
X-ray wavelength (Å) 1.0000 1.0000 1.0000 1.0000 
Space group C2 C2 C2 C2 
Unit cell length (a, b, c, Å) 270.5, 64.4, 106.4 271.4, 64.5, 106.3 271.5, 64.8, 106.9 271.1, 64.8, 106.9 
Unit cell angle (α, β, γ, °) 90, 104.1, 90 90, 104.2, 90 90, 104.2, 90 90, 104.1, 90 
Resolution range (Å) 50.0–1.92 (1.95–1.92)a 50–1.92 (1.95–1.92)a 50–1.79 (1.82–1.79)a 50–2.14 (2.18–2.14)a 
Total / unique reflections 955,775 / 136,288 905,894 / 134,717  1,267,763/ 169,178  689,619 / 97,978 
Completeness (%) 99.6 (98.8)a 99.3 (98.6)a 99.9 (98.7)a 100.0 (100.0)a 
Average I/σ (I) 28.6 (4.1)a 39.6 (12.0)a 42.2 (4.7)a 33.3 (4.5)a 
Rmergeb (%) 8.2 (50.1)a 8.9 (42.6)a 8.0 (50.9)a 11.3 (75.1)a 
     
B. Model refinement  
Resolution range (Å) 50.0–1.92 50.0–1.92 50.0–1.79 50.0–2.14 
Rwork / Rfreec (%) 16.8 / 20.0 16.7 / 20.3 16.4 / 19.3 15.9 / 19.7 
Monomers per asymmetric unit 4 4 4 4 
Number of non-hydrogen atoms / average B-factor (Å2) 
Protein  10,292 / 18.1 10,292 / 20.2 10,292 / 21.6 10,292 / 34.3 
Water oxygen 1,229 / 28.4 1,234 / 31.7 1,385 / 33.0 884 / 41.0 
Na+ 4 / 18.6 4 / 22.5 4 / 15.6 4 / 31.6 
NAD+ 4 / 13.4 4 / 14.4 4 / 16.3 4 / 28.6 
L-Pip - 4 / 17.9 - - 
L-Pro - - 4 / 25.5 - 
DABA - - - 4 / 42.0 
R.m.s. deviations from ideal geometry 
Bond lengths (Å) / bond angles (°) 0.008 / 1.39 0.008 / 1.41 0.008 / 1.48 0.008 / 1.39 
Protein-geometry analysis 
Ramachandran favored (%) 96.8  97.5  96.8  96.8 
Ramachandran allowed (%)  2.9 2.2 2.9 3.1 
Ramachandran outliers (%)  0.3 0.3 0.3 0.1 
a Values in parentheses refer to the highest resolution shell. 
b Rmerge = Σh Σi | I(h)i – < I(h) > | / Σh Σi I(h)i, where I(h) is the intensity of reflection h, Σh is the sum over all reflections, and Σi is the sum over 
i measurements of reflection h. 
c R = Σhkl | … |Fobs| – |Fcalc| | / Σhkl |Fobs|, where Rfree was calculated for a randomly chosen 5% of reflections, which were not used for 
structure refinement and Rwork was calculated for the remaining. 
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Cross-rotational and then translational searches were per-
formed using the PHASER program (McCoy et al., 2007). 
Subsequent manual model building was performed using 
the COOT program (Emsley and Cowtan, 2004) and re-
strained refinement was carried out using the PHENIX pro-
gram (Adams et al., 2002). Several rounds of model building, 
simulated annealing, positional refinement, and individual B-
factor refinement were performed using the COOT and 
PHENIX programs. Table 1 lists the refinement statistics. The 
atomic coordinates and structural factors for SpLCD/NAD+, 
SpLCD/NAD+/L-Pip, SpLCD/NAD+/L-Pro, and SpLCD/NAD+/L-
DABA complexes were deposited in PDB (accession codes 
5YU0, 5YU1, 5YU3, and 5YU4). 
 
Analytical gel filtration 
Purified SpLCD was subjected to analytical gel filtration 
chromatography using a Superdex 200 (10/300 GL) column 
with buffer A flowing at a constant rate of 0.5 ml/min (Choi 
et al., 2016). The standard curve was created using molecu-
lar weight markers (Sigma). The Stokes radii of β-amylase, 
alcohol dehydrogenase, carbonic anhydrase, and cytochrome 
C were calculated from the crystal structures of each protein 
(PDB entries 1FA2, 2HCY, 1V9E, and 1HRC, respectively) us-
ing the HYDROPRO program (Garcia De La Torre et al., 2000). 
 
Alignment of sequences 
The sequence of S. pristinaespiralis LCD was compared to 
the sequences of other LCDs and OCDs. The UniProtKB/ 
Swiss-Prot accession numbers of the sequences used were 
D9UBW0 (SpLCD), Q8RR22 (SvLCD) A0A0A0NQJ4 (SrLCD), 
E9KTB3 (SkLCD), U5VYY1 (AfLCD), Q9R468 (AtOCD), 
A0A179QU84 (PpOCD), A9WVR4 (BsOCD), C4IUX0 (BaOCD), 
and A0A0T7GIJ3 (NgOCD). Sequences were aligned using 
ClustalX (Thompson et al., 1997), and secondary structure 
elements were assigned using PyMOL (PyMOL Molecular 
Graphics System, http://www.pymol.org). 
 
 
 
A 
 
 
 
 
 
 
 
 
 
 
B 
 
 
 
 
 
 
 
 
 
C 
 
 
 
 
 
 
 
 
 
Fig. 1. Structure of Streptomyces pristinaespiralis LCD in complex with NAD+. (A) Stereo ribbon diagram of S. pristinaespiralis LCD 
(SpLCD)/NAD+ monomer. Helices are light pink, strands are magenta, and loops are grey.The yellow stick represents NAD+. All figures, 
including protein structures, were drawn using PyMOL software (The PyMOL Molecular Graphics System, http://www.pymol.org). (B) 
Ribbon diagram of SpLCD/NAD+ dimer. The height of the structure was measured after rotating the structure 90 degrees. (C) Analyti-
calgel filtration profile of SpLCD. Standard curve generated using molecular weight markers. The positions of the molecular weight 
markers for β-amylase, alcohol dehydrogenase, carbonic anhydrase, and cytochrome C are indicated with blue dots. The position of 
SpLCD is marked with a red dot. 
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RESULTS AND DISCUSSION 
 
Determination of the crystal structure of S. pristinaespiralis 
LCD 
Crystal structures of SpLCD were determined using the mo-
lecular replacement method based on the A. fulgidus ala-
nine dehydrogenase model (PDB entry 1OMO) (Gallagher et 
al., 2004) (Figs. 1A and 1B). The refined models for SpLCD/ 
NAD+, SpLCD/NAD+/L-Pip, SpLCD/NAD+/ L-Pro, and SpLCD/ 
NAD+/L-DABA had Rwork/Rfree values of 16.8/20.0% for 50-
1.92 Å, 16.7/20.3% for 50-1.92 Å, 16.4/19.3% for 50-
1.79 Å, and 15.9/19.7% for 50-2.14 Å, respectively (Table 
1). The last eleven disordered residues (345PLPLPLAAPAH355) 
of the C-termini are not shown for these structures. These 
residues are not conserved among LCDs, suggesting they are 
not critical for enzymatic functions. The refined model of 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2. Sequence alignment of SpLCD with LCDs and OCDs from other species. Multi-alignment of SpLCD (UniProtKB/Swiss-Prot acces-
sion numberD9UBW0) against LCD from Streptomyces virginiae(UniProtKB/Swiss-Prot accession numberQ8RR22), Streptomyces hygro-
scopicus(UniProtKB/Swiss-Prot accession numberA0A0A0NQJ4), Streptomyceskanamyceticus (UniProtKB/Swiss-Prot accession num-
berE9KTB3), Actinoplanes friuliensis(UniProtKB/Swiss-Prot accession numberU5VYY1), Agrobacterium tumefaciens (UniProtKB/Swiss-
Prot accession numberQ9R468), Pseudomonas putida(UniProtKB/Swiss-Prot accession numberA0A179QU84), Brucella suis biovar 
1(UniProtKB/Swiss-Prot accession numberA9WVR4), Brucella abortus biovar 1 (UniProtKB/Swiss-Prot accession numberC4IUX0), and 
Neorhizobium galegae by officinallis (UniProtKB/Swiss-Prot accession number A0A0T7GIJ3). Secondary structural elements were as-
signed using PyMOL and every twentieth residue is marked with a black dot. Strictly (100%) and semi-conserved residues (80%) are 
highlighted in green and light blue, respectively. Cylinders and arrows above the sequences denote α-helices and β-strands, respectively. 
Black, magenta, and cyan triangles below the LCD sequences denote L-pipecolic acid, L-proline, and L-DABA, respectively. Black boxes 
indicate residues interacting with water molecules when LCD or OCD bound its ligands and blue boxes denote residues interact with 
water molecules when LCD bound its cofactor; NAD+. Red and blue diamonds represent residues in the structures of SpLCD and Pseu-
domonas putida ornithine cyclodeaminase (PpOCD) that coordinate with NAD+and NADH, respectively. Residues interacting with L-
ornithine in OCD are shown in a pink triangle. 
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Fig. 3. A comparison of residues involved in 
coordination of NAD+ and NADH with
SpLCD-NAD+ and PpOCD-NADH. The resi-
dues involved in coordination of NAD+and
NADH with SpLCD-NAD+ (PDB entry 5YU0,
magenta) and PpOCD-NADH (PDB entry 
1U7H, cyan) were compared. Dashed lines 
represent hydrogen bonds. The residues 
interacting with NAD+and NADH are shown 
in magenta for SpLCD and cyan for PpOCD. 
Blue dots represent water molecules. A 2Fo-
Fc electron density map (1.0 σ) of the NAD+ 
molecule is presented at the bottom of the 
figure. 
 
SpLCD/NAD+ includes residues 1-344 in an asymmetric unit 
with 1,229 water molecules. Ramachandran plot analysis of 
the refined SpLCD/NAD+ model showed that 96.8, 2.9, and 
0.3% of the non-glycine residues were in the most favored, 
allowed, and disallowed regions, respectively (Table 1). The 
crystal structure of SpLCD/NAD+ primarily consisted of four-
teen strands and fifteen helices (Fig. 1A). The structure of 
SpLCD was comprised of a dimer of identical subunits, 
which corroborates with a previous study on PpOCD 
(Goodman et al., 2004) (Fig. 1B). Each subunit consisted of 
two domains that function in substrate binding, oligomeriza-
tion, and cofactor binding (Fig. 1B). Single dinucleotide 
bonds in each subunit were formed via a Rossmann fold (Fig. 
1B). The overall molecular dimension of the LCD dimer was 
50 × 80 × 45 Å with the two longest dimensions oriented in 
the plane presented in Fig. 1B. 
 
Overall structure and structural comparisons 
The overall structure of SpLCD resembled PpOCD, alanine 
dehydrogenase (AlaDH), and human μ-crystallin (CRYM). A 
search for structural similarity with SpLCD using the DALI 
server (Holm and Rosenstrom, 2010) identified crystal struc-
tures of OCD (PDB entry 1U7H) (Goodman et al., 2004), 
AlaDH (PDB entry 1OMO) (Gallagher et al., 2004), and 
CRYM (PDB entry 2I99) (Cheng et al., 2007). When the 
structure of SpLCD/NAD+ was overlaid with structures of 
OCD from Pseudomonas putida, AlaDH from A. fulgidus, 
and CRYM from humans, the r.m.s. deviations were 1.9 Å, 
2.0 Å, and 2.2 Å for the 335, 313, and 306 Cα atoms, re-
spectively. The PpOCD structure had the highest Z-score of 
43.8 when superimposed with SpLCD despite differences in 
the NAD+ binding site. To analyze the oligomeric state of 
SpLCD in solution, analytical gel filtration was performed 
using a Superdex 200 (10/300 GL) column. The Stokes radi-
us of SpLCD was estimated to be 3.91 nm, which is very 
similar to the Stokes radius calculated for the SpLCD dimer 
(3.43 nm) (Fig. 1C), suggesting that the SpLCD/NAD+ com-
plex exists as a homodimer in solution. The solvent-
accessible surface area buried at the interface between the 
two monomers measured 3132.8 Å2 (21.1% of the SpLCD 
monomer surface). Approximately 54% of the nonhydrogen 
atoms in the interface between the two monomers were 
polar, as indicated by the calculated proximal isovelocity 
surface areas (Krissinel and Henrick, 2007), which implied 
the interaction was mainly hydrophilic. 
 
NAD+ binding of SpLCD 
In general, the residues involved in NAD+ coordination at the 
active-site (Thr93, Arg121, Ala148, Gln149, Val233, and Ser301) 
were conserved between LCD and OCD (Figs. 2 and 3). 
However, there were some differences in the residues that 
interact with cofactors and substrates (Figs. 2 and 3). In the 
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Fig. 4. Stereo diagrams of SpLCD active sites around L-
pipecolic acid, L-proline, and L-DABA. Stereo diagrams
of the SpLCD active sites surrounding ligands (A) L-
pipecolic acid, (B) L-proline, and (C) L-DABA. Dashed
lines represent hydrogen bonds and blue dots indi-
cate water molecules. A 2Fo- Fc electron density map
(1.0 σ) for each ligand is shown to the right of each
stereo diagram. 
SpLCD/NAD+ complex, the main chain of Ala235 formed a 
hydrogen bond with the O3 atom of NAD+ (3.07 Å), while 
the side chain of Lys232 in PpOCD was involved in hydrogen 
bonding with the O3 atom of NAD+ (2.95 Å) (Fig. 3). The 
Lys232 side chain of PpOCD interacted with the O2 atom of 
NAD+ (2.75 Å) (Fig. 3). For hydrogen bonding with the O8 
and O9 atoms of NAD+, PpOCD used the side chain of Lys331 
(2.93 Å and 3.12 Å, respectively), while SpLCD used the 
side chain of His175 and two water molecules. The side chain 
of His175 formed a hydrogen bond with the O8 atom of 
NAD+ (2.85 Å), while two water molecules interacted with 
the O9 atom of NAD+. These two water molecules were 
sustained through hydrogen bonding with the Thr171 and 
Asp172 side chains (not shown) (Fig. 3). To create a hydrogen 
bond with O10 of NAD+, SpLCD used the main chain of 
Ser210 (2.32 Å), while PpOCD used Ala203 (3.34 Å) (Fig. 3). 
In the SpLCD/NAD+ complex, residues in SpLCD hydrogen 
bonds with water molecules indirectly coordinated with 
NAD+. The side chain of Glu307 indirectly interacted with the 
O1 atom of NAD+ through a water molecule (Fig. 2). In addi-
tion, the O4 atom of NAD+ interacted with Ile94 via a water 
molecule. The O5 atom of NAD+ interacted with a water 
molecule that then coordinated with three residues of 
SpLCD, Gly147, Ala150, and Ala208 (2.95 Å, 3.21 Å, and 2.95 
Å, respectively) (Fig. 2). The main chain of Pro83 formed a 
hydrogen bond with a water molecule (3.08 Å) that inter-
acted with the O7 atom of NAD+ (2.68 Å) and the side 
chain of Ser210 (2.77 Å). Finally, the main chain of Val218 
interacted with the N4 atom of NAD+ (2.84 Å) through a 
water molecule (2.70 Å) (Fig. 2). These direct and indirect 
hydrogen bonds between NAD+ and SpLCD residues create 
a stable SpLCD/NAD+ complex for catalysis. 
 
Structural insights into ligand recognition by SpLCD 
To obtain information on the binding between SpLCD and L-
lysine, we attempted to co-crystallize SpLCD with L-lysine. 
However, we instead obtained the electron-density map of 
L-Pip, the catalytic product of SpLCD (Fig. 4A), suggesting 
 
 
 
A 
 
 
 
 
 
 
 
 
 
 
 
 
B 
 
 
 
 
 
 
 
 
 
 
 
 
C 
 
 
 
 
 
Structural Basis for Ligand Recognition by LCD 
Kyungjin Min et al. 
 
 
8  Mol. Cells 2018; 41(4): 0-0 
 
 
the reaction occurred prior to crystallization. Similarly, the 
electron density map of L-Pro was obtained when SpLCD 
was co-crystallized with L-ornithine (Fig. 4B). When we at-
tempted to co-crystallize SpLCD with L-DABA, L-DABA was 
unable to be transformed in ring form. Instead, the electron 
density associated with L-DABA was observed (Fig. 4C). 
These results suggest that SpLCD has catalytic activity for L-
lysine and L-ornithine and L-DABA is too short for ring for-
mation. This is consistent with previous studies demonstrat-
ing SpLCD is able to perform catalysis on a range of sub-
strates of varying carbon lengths (Byun et al., 2015; Tsotsou 
and Barbirato, 2007). Structural comparisons of SpLCD in 
complex with L-Pip, L-Pro, and L-DABA revealed that bind-
ing of the carboxyl group attached to the C2 carbon was 
similar for each substrate (Fig. 4), suggesting this binding 
significantly contributes to substrate recognition. 
Next, we analyzed the binding of L-Pip and L-Pro to the 
active site of SpLCD. The side chains of Glu63, Lys77, and 
Arg121, and the main chain of Thr302, interacted with enzy-
matic products L-Pip and L-Pro (Figs. 4A and 4B). Interest-
ingly, the binding positions and orientations of L-Pip and L-
Pro were similar (Figs. 4A and 4B). In the SpLCD/L-Pip struc-
ture, the side chains of Lys77 and Arg121 interacted with the 
O1 (2.70 Å) and O2 atoms (2.91 Å) of L-Pip, respectively 
(Fig. 4A). In addition, the N1 atom of L-Pip interacted with 
the side chain of Thr302 (2.87 Å) (Fig. 4A). The side chain of 
Glu63 indirectly interacted with the N1 atom of L-Pip via one 
water molecule (Fig. 4A). For the SpLCD/L-Pro structure, the 
three residues Lys77, Arg121, and Thr302 were directly involved 
in hydrogen bonding with L-Pro (2.67 Å, 2.74 Å, and 3.20 
Å, respectively), while the side chain of Glu63 indirectly inter-
acted with the N1 atom of L-Pro via one water molecule in a 
manner similar to the SpLCD/L-Pip structure (Fig. 4B). 
To interact with L-DABA, additional side chains were re-
quired to stabilize L-DABA in the active site. The side chains 
of Glu63, Lys77, and Arg121, and the main chain of Thr302, 
formed hydrogen bonds with the N2 (3.25 Å), O2 (3.01 Å), 
O1 (2.81 Å), and N1 (2.93 Å) atoms of L-DABA, respectively 
(Fig. 4C). The carbonyl oxygen of Ala235 (3.20 Å) and O2 
atom of NAD+ (3.25 Å) formed hydrogen bonds with the N2 
atom of L-DABA (Fig. 4C). In addition, two water molecules 
formed hydrogen bonds, where one interacted with the 
Val79 (3.14 Å), Glu63 (2.79 Å), and N2 atoms of L-DABA 
(2.86 Å) and the other interacted with Arg49 (2.83 Å) and 
Glu63 (3.05 Å and 2.85 Å) and the N1 (2.71 Å) and N2 
(3.02 Å) atoms of NAD+ (Fig. 4C). 
To examine what makes L-Lys the optimal substrate for 
SpLCD, a composite model was created by incorporating the 
L-ornithine molecule from the PpOCD/L-ornithine structure 
into our SpLCD structure (Fig. 5A). The major difference  
 
 
 
A 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B 
 
 
 
 
 
 
 
 
 
Fig. 5. Hypothesized mechanism of catalysis by SpLCD. (A) The active sites of SpLCD/NAD+/L-DABA and PpOCD/NADH/L-ornithine are 
shown. The L-ornithine molecule with PpOCD was visualized in the active sites of SpLCD/NAD+/L-DABA by superimposing SpLCD and 
PpOCD. (B) Proposed catalytic mechanism of SpLCD. Dashed line represents the hydrogen bond between side chain of E63 and water 
molecule.
Structural Basis for Ligand Recognition by LCD 
Kyungjin Min et al. 
 
 
Mol. Cells 2018; 41(4): 0-0  9 
 
 
between SpLCD and PpOCD recognition of L-lysine and L-
ornithine, respectively, is the positioning of Asp236 in the 
substrate binding sites. In PpOCD, the Asp228 residue (resi-
due corresponding to SpLCD Asp236) interacted with Lys232 
(residue corresponding to SpLCD Lys240) with an additional 
hydrogen bond with O2 atom of NAD+, creating a space 
optimal for binding of L-ornithine. By contrast, the Asp236 
residue of SpLCD was in a slightly different position in SpLCD 
and formed a hydrogen bond with the O3 atom of NAD+. In 
addition, the side chain of SpLCD Lys240 was involved in dif-
ferent hydrogen bonding than PpOCD Lys232 (Fig. 5A). The 
different hydrogen bonds of Asp236, Lys240, and NAD+ in 
SpLCD created a space that accommodated L-lysine, which 
has one carbon more than L-ornithine. 
 
Proposed reaction mechanism of SpLCD 
The reaction mechanism of LCD has previously been exten-
sively studied using OCD and two distinct catalytic mecha-
nisms have been proposed (Graupner and White, 2001). In 
one proposal, the reaction proceeds through direct attack, 
where a water molecule becomes an imino intermediate 
(Graupner and White, 2001). The other proposal suggested 
that the δ-amino group directly attacks the C2 position of L-
ornithine without prior hydrolysis with the α-amino group 
subsequently leaving the intermediate molecule (Goodman 
et al., 2004). Despite the presence of two amino groups, α 
and δ, in L-ornithine, an elegant study using 15N-radiolabled 
ornithine determined that the α-amino group at the C2 posi-
tion is the amino group involved in cyclization (Graupner 
and White, 2001). Of the two proposals, the latter is plausi-
ble based on structural studies of PpOCD and SpLCD 
(Goodman et al., 2004; Ying et al., 2017b). In PpOCD, one 
water molecule resides near the C2 position of L-ornithine 
and binds the side chain of Glu56 and the α-amino group. 
However, the position of the water is not suitable for directly 
attacking the C2 carbon (Goodman et al., 2004). 
Despite extensive studies on the mechanism of catalysis of 
OCD, no structures of OCD in complex with its product, L-
Pro, have been reported. In this study, we solved the crystal 
structure of SpLCD in complex with several reaction products, 
including L-Pro and L-Pip, enabling us to confirm the previ-
ously proposed mechanism of catalysis. The LCD substrate L-
lysine contains one carbon more than the OCD substrate L-
ornithine. Therefore, the reaction mechanism may be similar. 
By elucidating the structure of SpLCD and comparing it to 
the PpOCD structure, we developed the following mecha-
nism. When L-lysine binds to the active site, the hydride ion 
is transferred to the NAD+ cofactor, resulting in an imino 
substitution (Fig. 5B). This process is facilitated by a neigh-
boring general base. In OCD, Asp228 has been suggested to 
be this general base because it is directly coordinated with 
an α-amino group (Goodman et al., 2004). However, Asp236 
of SpLCD, the residue corresponding with Asp236, is located 
far from the α-amino group (Fig. 5A). Rather, a water mole-
cule forms a hydrogen bond with the α-amino group and 
the side chain of Glu63 (Fig. 5A), suggesting that the water 
molecule may serve as general base by donating a proton to 
Glu63. The next step is direct attack of the δ-amino group to 
the C2 position of the intermediate molecule in order to 
form the six-membered ring of L-Pip (Fig. 5B). The leaving 
group, ammonia, goes away and the electrophilic C2 center 
is susceptible to hydride ion transfer from NADH, yielding L-
Pip and NAD+ as products. 
This proposed mechanism is similar to that proposed for 
PpOCD and is based on an unusual NAD+/NADH cycle. In 
canonical NAD+ (or NADH) bound enzymes, NAD+ (or 
NADH) is unidirectionally converted into NADH (or NAD+) to 
mediate oxidation/reduction reactions. However, in SpLCD, 
NAD+ is converted into NADH at the intermediate step and 
then reverted back to NAD+. This mechanism could be bene-
ficial for producing L-Pip, which is a useful precursor in 
pharmaceutical synthesis, because it does not require NADH 
molecules to be continually supplied during synthesis. 
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